Provident Healthcare Partners Advises Acentus in its Acquisition by Henry Schein
| HSIC Stock | USD 79.85 2.06 2.51% |
About 61% of Henry Schein's investor base is looking to short. The analysis of the overall prospects from investing in Henry Schein suggests that many traders are, at the present time, alarmed. The current market sentiment, together with Henry Schein's historical and current headlines, can help investors time the market. In addition, many technical investors use Henry Schein stock news signals to limit their universe of possible portfolio assets.
Henry |
Provident Healthcare Partners , a leading healthcare investment banking firm, announced it has advised Acentus in the acquisition of substantially all of its assets by Henry Schein, Inc. Acentus is a national medical supplier specializing in the delivery of Continuous Glucose Monitors . Acentus Founders Brett Carroll, Todd Cianfrocca, Greg Duvall, and Julio Valdivia will join Henry Schein, bringing their expertise and experience in the product category and the healthcare indus
Read at finance.yahoo.com
 |
Henry Schein Fundamental Analysis
We analyze Henry Schein's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Henry Schein using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Henry Schein based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Beta
Beta Comparative Analysis
Henry Schein is currently under evaluation in beta category among its peers. Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Henry Schein Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Henry Schein stock to make a market-neutral strategy. Peer analysis of Henry Schein could also be used in its relative valuation, which is a method of valuing Henry Schein by comparing valuation metrics with similar companies.
Peers
Henry Schein Related Equities
| PDCO | Patterson Companies | 0.06 | ||||
| CAH | Cardinal Health | 0.31 | ||||
| ZYXI | Zynex | 0.88 | ||||
| MCK | McKesson | 1.18 | ||||
| EDAP | EDAP TMS | 2.75 | ||||
| OMI | Owens Minor | 2.81 |
Complementary Tools for Henry Stock analysis
When running Henry Schein's price analysis, check to measure Henry Schein's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Henry Schein is operating at the current time. Most of Henry Schein's value examination focuses on studying past and present price action to predict the probability of Henry Schein's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Henry Schein's price. Additionally, you may evaluate how the addition of Henry Schein to your portfolios can decrease your overall portfolio volatility.
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |